Detalhe da pesquisa
1.
New Hybrid Pyrazole and Imidazopyrazole Antinflammatory Agents Able to Reduce ROS Production in Different Biological Targets.
Molecules
; 25(4)2020 Feb 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32085423
2.
Synthesis, biological activities and pharmacokinetic properties of new fluorinated derivatives of selective PDE4D inhibitors.
Bioorg Med Chem
; 23(13): 3426-35, 2015 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25936260
3.
Design, synthesis, biological evaluation and structural characterization of novel GEBR library PDE4D inhibitors.
Eur J Med Chem
; 223: 113638, 2021 Nov 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34171658
4.
Autologous Platelet Rich Plasma (PRP) in the treatment of elbow epicondylitis and plantar fasciitis: medium to long term clinical outcome.
Acta Biomed
; 91(14-S): e2020029, 2020 12 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33559623
5.
New insights into selective PDE4D inhibitors: 3-(Cyclopentyloxy)-4-methoxybenzaldehyde O-(2-(2,6-dimethylmorpholino)-2-oxoethyl) oxime (GEBR-7b) structural development and promising activities to restore memory impairment.
Eur J Med Chem
; 124: 82-102, 2016 Nov 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-27560284
6.
Synthesis, biological evaluation, and molecular modeling of new 3-(cyclopentyloxy)-4-methoxybenzaldehyde O-(2-(2,6-dimethylmorpholino)-2-oxoethyl) Oxime (GEBR-7b) related phosphodiesterase 4D (PDE4D) inhibitors.
J Med Chem
; 57(16): 7061-72, 2014 Aug 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-25126889